U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$690.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$411.9b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Thermo Fisher Scientific

Market Cap: US$176.2b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Danaher

Market Cap: US$141.4b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Zoetis

Market Cap: US$67.6b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

IQVIA Holdings

Market Cap: US$31.1b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Natera

Market Cap: US$18.6b

A diagnostics company, provides molecular testing services worldwide.

Waters

Market Cap: US$17.0b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Incyte

Market Cap: US$15.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

ICON

Market Cap: US$12.8b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Medpace Holdings

Market Cap: US$12.1b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Qiagen

Market Cap: US$10.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Revvity

Market Cap: US$10.4b

Provides health sciences solutions, technologies, and services worldwide.

Caris Life Sciences

Market Cap: US$8.2b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Repligen

Market Cap: US$6.5b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Alkermes

Market Cap: US$4.4b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Prestige Consumer Healthcare

Market Cap: US$3.7b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$2.6b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ligand Pharmaceuticals

Market Cap: US$2.6b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Supernus Pharmaceuticals

Market Cap: US$2.3b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Disc Medicine

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

BioLife Solutions

Market Cap: US$999.3m

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Niagen Bioscience

Market Cap: US$760.9m

Operates as a bioscience company engages in developing healthy aging products.

CareDx

Market Cap: US$701.6m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Tilray Brands

Market Cap: US$667.7m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Mesa Laboratories

Market Cap: US$420.9m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Pacific Biosciences of California

Market Cap: US$417.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

MariMed

Market Cap: US$38.9m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Pharma-Bio Serv

Market Cap: US$13.8m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.